These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 336176)
41. Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Law MR; Gregor A; Hodson ME; Bloom HJ; Turner-Warwick M Thorax; 1984 Apr; 39(4):255-9. PubMed ID: 6426072 [TBL] [Abstract][Full Text] [Related]
42. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo). Case DC J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513 [No Abstract] [Full Text] [Related]
43. Improved chemotherapy for small-cell undifferentiated lung cancer. Einhorn LH; Fee WH; Farber MO; Livingston RB; Gottlieb JA JAMA; 1976 Mar; 235(12):1225-9. PubMed ID: 55504 [TBL] [Abstract][Full Text] [Related]
44. [Combination chemotherapy of anaplastic carcinoma with adriamycin, vincristine, methotrexate and cyclophosphamide (author's transl)]. Chauvergne J; Durand M; Hoerni B; Brunet R; Bui BN Bull Cancer; 1980; 67(2):167-74. PubMed ID: 7448439 [TBL] [Abstract][Full Text] [Related]
45. Cyclical combination chemotherapeutic regimen in adult soft tissue sarcoma. Dalley DN; Levi JA; Nesbitt RA; Tattersall MH; Woods RL; Fox RM; Aroney RS Cancer Clin Trials; 1981; 4(2):163-5. PubMed ID: 7249252 [TBL] [Abstract][Full Text] [Related]
46. Chemotherapy in the treatment of malignant mesothelioma. Aisner J; Wiernik PH Semin Oncol; 1981 Sep; 8(3):335-43. PubMed ID: 7280716 [No Abstract] [Full Text] [Related]
47. [Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973]. Walser A; Alberto P Schweiz Med Wochenschr; 1977 Apr; 107(16):569-77. PubMed ID: 67638 [TBL] [Abstract][Full Text] [Related]
48. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510 [TBL] [Abstract][Full Text] [Related]
49. [The practice of chemotherapy with the DeVita protocol]. Gassmann W; Schmitz N; Löffler H Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488 [No Abstract] [Full Text] [Related]
50. Combination chemotherapy of germ cell tumors of the testis with vincristine, adriamycin, cyclophosphamide, actinomycin D and medroxyprogesterone acetate. Klepp O; Klepp R; Host H; Asbjornsen G; Talle K; Stenwig AE Cancer; 1977 Aug; 40(2):638-46. PubMed ID: 70266 [TBL] [Abstract][Full Text] [Related]
51. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma. Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102 [No Abstract] [Full Text] [Related]
53. Immunochemotherapy in advanced neuroblastoma. Necheles TF; Rausen AR; Kung FH; Pochedly C Cancer; 1978 Apr; 41(4):1282-8. PubMed ID: 638992 [TBL] [Abstract][Full Text] [Related]
54. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)]. Mutz ID; Urban CE Wien Klin Wochenschr; 1978 Dec; 90(24):867-70. PubMed ID: 741754 [TBL] [Abstract][Full Text] [Related]
55. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]. Michlmayr G; Kratzer H; Denz H; Huber H Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697 [TBL] [Abstract][Full Text] [Related]
56. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial. Heuson JC; Sylvester R; Engelsman E Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920 [No Abstract] [Full Text] [Related]
57. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo). Case DC Oncology; 1983; 40(3):186-91. PubMed ID: 6189041 [TBL] [Abstract][Full Text] [Related]
58. The CYVADIC regimen as a combination chemotherapy treatment option for advanced soft tissue sarcomas originating from the non-extremities. Nakano K; Motoi N; Takahashi S Intern Med; 2015; 54(2):187-93. PubMed ID: 25743010 [TBL] [Abstract][Full Text] [Related]
59. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060 [TBL] [Abstract][Full Text] [Related]
60. Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). Gasparini M; Bellani FF; Musumeci R; Bonadonna G Cancer Chemother Rep; 1974; 58(3):365-70. PubMed ID: 4601666 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]